Biotech raised $6bn in 2014 venture capital; most since 2007
This article was originally published in Scrip
Executive Summary
Biotechnology companies ended 2014 with $6bn in new venture capital in their pockets, which was the biggest annual total since 2007, but that's after private startups and early-stage businesses raised $2bn in the fourth quarter alone – the biggest single-quarter total in at least 19 years.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports